In other studies, PNPLA3 and TM6SF2 variants were noted as potential risk factors for MASLD, and it was observed that AA had a lower frequency of the PNPLA3 variant compared to other ethnic groups [52]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.